Pfizer stands at the apex of the pharmaceutical industry. And while its position as the world’s largest pharmaceutical company may be doubted, its contribution cannot be. And at the apex of the Pfizer company stands, Albert Bourla. The newly appointed CEO of the company, Bourla leads the company with a single goal, breakthroughs that change patients’ lives. Known for his dynamic leadership style, Bourla has enjoyed a diverse and successful career with Pfizer. In his 25-year stay at the company, Bourla has served in different capacities and has been successful in roles allocated to him. In this article, we take a closer look at the wiki-bio of Alber Bourla.
Albert Bourla was born in 1962 in Greece. Born and raised in Greece, Albert was the only child in the Bourla household. He developed an interest in the field of medicine when he was quite young and wanted to be a doctor. After finishing his education at a local high school, Albert started working for his veterinary degree at the Aristotle University of Thessaloniki in 1979. He later received his Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University.
Albert Bourla has been a one-company man throughout his career. He began his career at Pfizer in 1993 and is now the CEO of the company. Albert joined the company as Technical Director of the Animal Health Division in Greece. During his time in Greece, Albert worked for the betterment of Animal Health across Europe. In 2001, Albert was invited to work at the headquarters of Pfizer located in New York.
Through his hard work and dedication in his work, Albert continued serving the company in several roles. In his first 10 years in New York Albert worked as the US Group Marketing Director (2001-2004), Vice President of Business Development and New Products Marketing (2004-2006), and Area President of Animal Health Europe, Africa and the Middle East (2006-2009). In 2009, Albert was also asked to take responsibility for the Asia and Pacific regions.
Albert’s first big managerial role came in 2010 when he was appointed in the post of General Manager for Pfizer’s Established Products business from 2010-2013. In 2014, Albert switched over as Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business. During his tenure, Albert helped the company to make a breakthrough in the vaccine market.
Moving on Albert was appointed as the Group President of Pfizer Innovative Health. He held the position from February 2016 to December 2017 and was responsible for Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease, and Vaccines business groups. Promotion came quickly for Albert who was appointed as the Chief Operating Officer (COO) effective from January 2018. And after 25 years at the company, Albert was handed over the reins of Pfizer. In January of 2019, Albert assumed office as the CEO. And while there were no questions regarding his capabilities, Albert proved his worth once again and was named America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine.
Personal Life and Net Worth:
As Albert stays away from social media and media in general, it is very hard to find details on his personal life. Albert is married to an unidentified woman. There are no details on his wife and possible children. AS of 2020, Albert has a total net worth of USD 22.8 million.
Albert has always dedicated his work to the betterment of medical science. Over the years, Albert has served in a different capacity at several groups like The Partnership for New York City, United States Council for International Business, and Business Round-table and the Business Council.